DBV Technologies
Price & Volume
Stats
See moreOpen | $7.08 |
Previous Close | $7.86 |
Day Range | $6.93-$7.36 |
52W Range | $2.20-$8.50 |
Market Cap | $161.2M |
Shares Short | 340,543 |
Financials
See moreRevenue (12 Mos) | $4.2M |
Revenue Growth (YoY) | -93.7% |
Gross Profit (12 Mos) | $4.2M |
Diluted EPS | -$5.85 |
News
See moreYahoo Finance • last year
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
Yahoo Finance • 2 years ago
DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old
Yahoo Finance • 2 years ago
DBV Technologies to Report Third Quarter 2022 Financial Results and Provide a Business Update
Yahoo Finance • 3 years ago
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
About
CEO | Mr. Daniel Tassé |
CFO | Ms. Virginie Simone Jeanine Verrechia Boucinha M.B.A. |
Address | 177-181 Avenue Pierre Brossolette, Montrouge, France, 92120 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
